Tag

Healthcare Services

6 articles
Healthcare services companies demonstrated robust growth in the second quarter, fueled by both organic expansion and strategic acquisitions. Aster DM Quality Care reported a 19% revenue increase and a 34% rise in normalized profit, while Kaya Limited saw a 21% revenue jump despite a narrowed loss. Paras Healthcare posted a significant 226% surge in profit, and IKS Health’s revenue soared 104% following the TruBridge acquisition, reflecting a trend of consolidation and operational improvements within the sector. These results suggest a resilient demand for healthcare services and highlight the potential for continued growth, though GST changes and regulatory compliance remain key considerations for investors.
QMS Medical Allied Services Q2 PAT Down 32% YoY
Announced composite scheme to merge PSP businesses with HCAH India into Saarathi Healthcare via all-share swap. Q2 FY27 consolidated revenue grew 18% YoY to ₹52.5 crore while PAT declined 32% to ₹2.4
Arvaya Healthcare Q2 FY27 Revenue ₹40.28 Cr, PAT ₹1.37 Cr
Arvaya Healthcare disclosed its Q2 & H1 FY27 unaudited results via a BSE filing, reporting a consolidated revenue of ₹40.28 Cr and PAT of ₹1.37 Cr for the quarter. The company operates a network of 9
Jeena Sikho Lifecare Q2 FY27 Financial Results
Jeena Sikho Lifecare Board approved Q2 FY27 standalone and consolidated unaudited financial results for quarter ended September 30, 2026. Standalone net profit for Q2 stood at ₹36.34 crore on revenue
Family Care Hospitals Q2 FY27 Net Loss ₹73.75 Lakh
Board approved unaudited standalone financial results for Q2 and year ended September 30, 2026, reporting a quarterly net loss of ₹73.75 lakh. Company carries ₹38.03 crore in discount coupon vouchers
Medanta Q2 Revenue Up 34% YoY with 60% EBITDA Growth
Global Health Limited reported Q2 FY2027 revenue growth of 33.6% YoY to ₹14,690 million driven by 29.5% inpatient volume growth. Operating EBITDA surged 60.2% YoY to ₹3,701 million with margins expand
Family Care Hospitals Q2 FY27 Loss ₹73.75 Lakh
• Board approved unaudited standalone financial results for Q2 and year ended September 30, 2026, as per SEBI Regulation 33. • Company reported a net loss of ₹73.75 lakh for Q2 FY27 and ₹116.12 lakh f